Talk:Emmonsia parva

Fungi Low‑importance

	Fungi portal This article is within the scope of WikiProject Fungi, a collaborative effort to improve the coverage of Fungi on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.FungiWikipedia:WikiProject FungiTemplate:WikiProject FungiFungi articles
Low	This article has been rated as Low-importance on the project's importance scale.
	An editor has requested that an image or photograph be added to this article.

This article was the subject of an educational assignment in 2014 Q3. Further details were available on the "Education Program:University of Toronto/HMB436H Medical and Veterinary Mycology (2014 Fall)" page, which is now unavailable on the wiki.

Assignment 2

Linking is good. Make sure that the taxbox is correct. Watch spellings - adiaspiromycosis; gows; airbourne. Are Emmonsia parva and Emmonsia crescens the same thing? Does this name apply to the sexual or a sexual state of the fungus? Make sure that you put all Latin names in italics, and capitalize the genus name. What kinds of diseases does it cause? What is known about treatment? Is this agent known regularly as pathogen of humans or animals or both? Is there any vitamin dependency or anything else that might be known about the physiology of this fungus? Can you find any references on any of these points? Medmyco (talk) 21:40, 18 October 2014 (UTC)[reply]

Comments regarding article progression

Well done with the compilation of your facts! Your sources have many of the same facts as those I could find and the study on your species has been fairly limited as far as a cursory search suggests. Some aspects you may want to consider incorporating into your article are the following:

· Tie in the lack of fulminant disease state to the the inability of the fungus to reproduce while in tissue. The spores, following inhalation, grow and increase in size without budding, causing a self-limiting pathology as the immune response has been characterized as scaling to the spore size (DOI: 10.1016/j.clinmicnews.2011.08.002) (this article also details a rare occurrence in the character of cutaneous adiospiromycosis - it may be worth a mention)

· Mention that E. parva represented the first documented case of adiospiromycosis. This same article notes the difficulty of inducing the adiaspore growth in culture and states that a very specific medium is required - notably, a thiamine supplement, suggesting an auxotrophy (DOI: 10.1080/00362177585190111)

· Small notes regarding your facts: you wrote chrysospoium where you mean chrysosporium (be careful when incorporating this into the main article) and you have the genus "Pseudallescheria" listed in your taxabox but "Emmonsia" in the body of your article. I'm not sure about the confusing taxonomic details but if these are the same thing, you should make note of it somewhere. Best of luck with your assignment! MediSyntax (talk) 00:43, 2 November 2014 (UTC)[reply]

Current name

Index Fungorum gives the current name for this species as Ajellomyces crescens Sigler 1996, indicating that this is the teleomorph (source is J. Med. Vet. Mycol. 34(5): 305 (1996)). Should we move this page to this name? 17:05, 16 November 2014 (UTC)

I'd be inclined to leave it as E. parva for the moment. Apart from the terminal groups, there isn't a great deal of structure within this clade based on the tree we published in Mycologia, 96(4), 2004, pp. 812–821 and I'd want to see other gene regions first. Since anyone looking for the agent of adiasporomycosis is more likely to end up at the genus Emmonsia than Ajellomyces, leaving the page where it is until the taxonomy is clearer might make it more accessible. Medmyco (talk) 21:19, 12 June 2015 (UTC)[reply]